Fig. 3From: Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case reportDisease status before and after neoadjuvant osimertinib therapy. a, b Positron emission tomography/computed tomography 10 months after diagnosis and 4 months after surgery. No evidence of diseaseBack to article page